Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.071 | 0.7 |